Analysis

For shareholders of 5barz International, a complete lack of financial disclosure continues to shroud the company in mystery. The telecommunications...

The video game industry is navigating a period of significant headwinds. As competitor Epic Games contends with declining user engagement...

The U.S. Food and Drug Administration (FDA) has taken decisive action against ImmunityBio, issuing a formal warning letter over what...

Consumers and businesses looking to purchase new computing hardware are facing significantly higher costs. Advanced Micro Devices (AMD) is reportedly...

While Eli Lilly continues to post impressive prescription figures for its blockbuster weight-loss medications, a growing sense of unease is...

The launch of the highly anticipated Wegovy pill on the Hims & Hers platform has been met with a tepid...

A broad sell-off in technology equities, driven by heightened geopolitical tensions between the United States and Iran alongside oil prices...

Rocket Lab's latest move to secure funding has unsettled the market, casting a shadow over recent operational successes. The space...

While Snowflake is advancing its vision for an "agentic enterprise" through new autonomous technology, the cloud data specialist confronts a...

While its financial runway extends into 2028, Precision Biosciences (NASDAQ: DTIL) faces a period of clinical anticipation that is testing...